Cargando…
Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells
Costly coagulation factor VIII (FVIII) replacement therapy is a barrier to optimal clinical management of hemophilia A. Therapy using FVIII-secreting autologous primary cells is potentially efficacious and more affordable. Zinc finger nucleases (ZFN) mediate transgene integration into the AAVS1 locu...
Autores principales: | Sivalingam, Jaichandran, Kenanov, Dimitar, Han, Hao, Nirmal, Ajit Johnson, Ng, Wai Har, Lee, Sze Sing, Masilamani, Jeyakumar, Phan, Toan Thang, Maurer-Stroh, Sebastian, Kon, Oi Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786920/ https://www.ncbi.nlm.nih.gov/pubmed/26689265 http://dx.doi.org/10.1038/mt.2015.223 |
Ejemplares similares
-
Durable engraftment of genetically modified FVIII‐secreting autologous bone marrow stromal cells in the intramedullary microenvironment
por: Lee, Sze Sing, et al.
Publicado: (2018) -
Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity
por: Enkirch, Theresa, et al.
Publicado: (2019) -
Safety Evaluation of Human Cord-Lining Epithelial Stem Cells
Transplantation for Liver Regeneration in a Porcine Model
por: Lim, Raymond Hon Giat, et al.
Publicado: (2020) -
Targeted gene knockout by direct delivery of ZFN proteins
por: Gaj, Thomas, et al.
Publicado: (2012) -
An optimized two-finger archive for ZFN-mediated gene targeting
por: Gupta, Ankit, et al.
Publicado: (2012)